NINLX vs. NHS

Last updated Jun 24, 2026

NINLX (Neuberger Berman Intrinsic Value Fund) and NHS (Neuberger Berman High Yield Strategies Fund) are both mutual funds - NINLX is a Small Cap Blend Equities fund managed by Neuberger Berman, while NHS is a High Yield Bonds fund actively managed by Neuberger Berman. Over the past 10 years, NINLX returned 13.12%/yr vs 5.33%/yr for NHS. At a 0.37 correlation, their price movements are largely independent. NINLX charges 1.01%/yr vs 4.14%/yr for NHS.

Performance

NINLX vs. NHS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Neuberger Berman Intrinsic Value Fund (NINLX) and Neuberger Berman High Yield Strategies Fund (NHS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, NINLX achieves a 23.42% return, which is significantly higher than NHS's -10.80% return. Over the past 10 years, NINLX has outperformed NHS with an annualized return of 13.12%, while NHS has yielded a comparatively lower 5.33% annualized return.

NINLX

• 1D: -0.33%
• 1M: 2.90%
• YTD: 23.42%
• 6M: 21.53%
• 1Y: 54.93%
• 3Y*: 19.54%
• 5Y*: 7.82%
• 10Y*: 13.12%

NHS

• 1D: -0.49%
• 1M: -1.46%
• YTD: -10.80%
• 6M: -6.99%
• 1Y: -3.24%
• 3Y*: 7.60%
• 5Y*: -2.02%
• 10Y*: 5.33%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NINLX vs. NHS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NINLX Neuberger Berman Intrinsic Value Fund	23.42%	18.20%	7.62%	13.89%	-20.22%	26.42%	27.14%	24.92%	-10.56%	16.81%
NHS Neuberger Berman High Yield Strategies Fund	-10.80%	14.81%	11.04%	6.12%	-22.99%	15.78%	4.57%	39.03%	-11.45%	8.64%

Correlation

The correlation between NINLX and NHS is 0.37, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.37
Correlation (3Y) Calculated over the trailing 3-year period	0.32
Correlation (5Y) Calculated over the trailing 5-year period	0.41
Correlation (10Y) Calculated over the trailing 10-year period	0.41
Correlation (All Time) Calculated using the full available price history since Jul 29, 2003	0.37

Return for Risk

NINLX vs. NHS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NINLX

NINLX Risk / Return Rank: 87
NINLX Sharpe Ratio Rank: 89
NINLX Sortino Ratio Rank: 80
NINLX Omega Ratio Rank: 72
NINLX Calmar Ratio Rank: 96
NINLX Martin Ratio Rank: 96

NHS

NHS Risk / Return Rank: 2
NHS Sharpe Ratio Rank: 2
NHS Sortino Ratio Rank: 2
NHS Omega Ratio Rank: 2
NHS Calmar Ratio Rank: 2
NHS Martin Ratio Rank: 2

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NINLX vs. NHS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Neuberger Berman Intrinsic Value Fund (NINLX) and Neuberger Berman High Yield Strategies Fund (NHS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	NINLX	NHS	Difference
Sharpe ratio: Return per unit of total volatility	2.70	-0.26	+2.96
Sortino ratio: Return per unit of downside risk	3.47	-0.27	+3.74
Omega ratio: Gain probability vs. loss probability	1.43	0.96	+0.47
Calmar ratio: Return relative to maximum drawdown	6.06	-0.19	+6.25
Martin ratio: Return relative to average drawdown	21.52	-0.43	+21.95

NINLX vs. NHS - Sharpe Ratio Comparison

The current NINLX Sharpe Ratio is 2.70, which is higher than the NHS Sharpe Ratio of -0.26. The chart below compares the historical Sharpe Ratios of NINLX and NHS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

NINLX vs. NHS - Drawdown Comparison

The maximum NINLX drawdown since its inception was -59.95%, smaller than the maximum NHS drawdown of -64.67%. Use the drawdown chart below to compare losses from any high point for NINLX and NHS.

Drawdown Indicators

	NINLX	NHS	Difference
Max Drawdown Largest peak-to-trough decline	-59.95%	-64.67%	+4.72%
Max Drawdown (1Y) Largest decline over 1 year	-9.39%	-17.01%	+7.62%
Max Drawdown (3Y) Largest decline over 3 years	-26.46%	-17.01%	-9.45%
Max Drawdown (5Y) Largest decline over 5 years	-28.71%	-37.43%	+8.72%
Max Drawdown (10Y) Largest decline over 10 years	-44.43%	-42.97%	-1.46%
Current Drawdown Current decline from peak	-1.56%	-16.18%	+14.62%
Average Drawdown Average peak-to-trough decline	-9.89%	-8.87%	-1.02%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.63%	7.55%	-4.92%

Volatility

NINLX vs. NHS - Volatility Comparison

Neuberger Berman Intrinsic Value Fund (NINLX) has a higher volatility of 7.43% compared to Neuberger Berman High Yield Strategies Fund (NHS) at 3.14%. This indicates that NINLX's price experiences larger fluctuations and is considered to be riskier than NHS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NINLX	NHS	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.43%	3.14%	+4.29%
Volatility (6M) Calculated over the trailing 6-month period	15.41%	10.11%	+5.30%
Volatility (1Y) Calculated over the trailing 1-year period	21.08%	12.95%	+8.13%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	21.88%	16.17%	+5.71%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	23.17%	16.71%	+6.46%

NINLX vs. NHS - Expense Ratio Comparison

NINLX has a 1.01% expense ratio, which is lower than NHS's 4.14% expense ratio.

Dividends

NINLX vs. NHS - Dividend Comparison

NINLX's dividend yield for the trailing twelve months is around 3.45%, less than NHS's 17.74% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NHS Neuberger Berman High Yield Strategies Fund	17.74%	14.60%	14.50%	13.94%	12.75%	8.74%	9.29%	7.99%	8.37%	7.59%	8.23%	9.81%
NINLX Neuberger Berman Intrinsic Value Fund	3.45%	4.25%	0.92%	0.25%	3.76%	6.40%	1.62%	2.85%	14.51%	5.19%	1.42%	5.22%

Frequently Asked Questions

Can I hold both NINLX and NHS in my portfolio?

NINLX and NHS have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, NINLX or NHS?

NINLX has higher volatility (7.43%) compared to NHS (3.14%). In terms of maximum drawdown, NINLX dropped -59.95% vs NHS's -64.67%.

Which has better risk-adjusted returns?

NINLX currently has the higher Sharpe Ratio (2.70 vs -0.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.